Understanding the role of the news media in HPV vaccine uptake in the United States: Synthesis and commentary

Research output: Contribution to journalComment/debate

20 Citations (Scopus)

Abstract

ABSTRACT: Vaccination rates for the human papillomavirus (HPV) vaccine fall below targets and only 2 states and the District of Columbia require the vaccine for middle school-age children. Messages conveyed through news media—to parents, providers, policymakers, and the general public—may contribute to sluggish vaccination rates and policy action. In this commentary, we review the findings from 13 published studies of news media coverage of the HPV vaccine in the United States since FDA licensure in 2006. We find 2 important themes in news coverage: a rising focus on political controversy and a consistent emphasis on the vaccine as for girls, even beyond the point when the vaccine was recommended for boys. These political and gendered messages have consequences for public understanding of the vaccine. Future research should continue to monitor news media depictions of the HPV vaccine to assess whether political controversy will remain a pronounced theme of coverage or whether the media ultimately depict the vaccine as a routine public health service.

Original languageEnglish (US)
Pages (from-to)1430-1434
Number of pages5
JournalHuman Vaccines and Immunotherapeutics
Volume12
Issue number6
DOIs
StatePublished - Jun 2 2016

Fingerprint

Papillomavirus Vaccines
Vaccines
Vaccination
United States Public Health Service
Licensure
Parents

Keywords

  • HPV vaccine
  • health communication
  • media
  • policy

Cite this

@article{fb81663820d04ae2860b7125483eab22,
title = "Understanding the role of the news media in HPV vaccine uptake in the United States: Synthesis and commentary",
abstract = "ABSTRACT: Vaccination rates for the human papillomavirus (HPV) vaccine fall below targets and only 2 states and the District of Columbia require the vaccine for middle school-age children. Messages conveyed through news media—to parents, providers, policymakers, and the general public—may contribute to sluggish vaccination rates and policy action. In this commentary, we review the findings from 13 published studies of news media coverage of the HPV vaccine in the United States since FDA licensure in 2006. We find 2 important themes in news coverage: a rising focus on political controversy and a consistent emphasis on the vaccine as for girls, even beyond the point when the vaccine was recommended for boys. These political and gendered messages have consequences for public understanding of the vaccine. Future research should continue to monitor news media depictions of the HPV vaccine to assess whether political controversy will remain a pronounced theme of coverage or whether the media ultimately depict the vaccine as a routine public health service.",
keywords = "HPV vaccine, health communication, media, policy",
author = "Gollust, {Sarah E.} and LoRusso, {Susan M.} and Nagler, {Rebekah H.} and Fowler, {Erika Franklin}",
year = "2016",
month = "6",
day = "2",
doi = "10.1080/21645515.2015.1109169",
language = "English (US)",
volume = "12",
pages = "1430--1434",
journal = "Human Vaccines and Immunotherapeutics",
issn = "2164-5515",
publisher = "Landes Bioscience",
number = "6",

}

TY - JOUR

T1 - Understanding the role of the news media in HPV vaccine uptake in the United States

T2 - Synthesis and commentary

AU - Gollust, Sarah E.

AU - LoRusso, Susan M.

AU - Nagler, Rebekah H.

AU - Fowler, Erika Franklin

PY - 2016/6/2

Y1 - 2016/6/2

N2 - ABSTRACT: Vaccination rates for the human papillomavirus (HPV) vaccine fall below targets and only 2 states and the District of Columbia require the vaccine for middle school-age children. Messages conveyed through news media—to parents, providers, policymakers, and the general public—may contribute to sluggish vaccination rates and policy action. In this commentary, we review the findings from 13 published studies of news media coverage of the HPV vaccine in the United States since FDA licensure in 2006. We find 2 important themes in news coverage: a rising focus on political controversy and a consistent emphasis on the vaccine as for girls, even beyond the point when the vaccine was recommended for boys. These political and gendered messages have consequences for public understanding of the vaccine. Future research should continue to monitor news media depictions of the HPV vaccine to assess whether political controversy will remain a pronounced theme of coverage or whether the media ultimately depict the vaccine as a routine public health service.

AB - ABSTRACT: Vaccination rates for the human papillomavirus (HPV) vaccine fall below targets and only 2 states and the District of Columbia require the vaccine for middle school-age children. Messages conveyed through news media—to parents, providers, policymakers, and the general public—may contribute to sluggish vaccination rates and policy action. In this commentary, we review the findings from 13 published studies of news media coverage of the HPV vaccine in the United States since FDA licensure in 2006. We find 2 important themes in news coverage: a rising focus on political controversy and a consistent emphasis on the vaccine as for girls, even beyond the point when the vaccine was recommended for boys. These political and gendered messages have consequences for public understanding of the vaccine. Future research should continue to monitor news media depictions of the HPV vaccine to assess whether political controversy will remain a pronounced theme of coverage or whether the media ultimately depict the vaccine as a routine public health service.

KW - HPV vaccine

KW - health communication

KW - media

KW - policy

UR - http://www.scopus.com/inward/record.url?scp=84961216978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961216978&partnerID=8YFLogxK

U2 - 10.1080/21645515.2015.1109169

DO - 10.1080/21645515.2015.1109169

M3 - Comment/debate

C2 - 26554612

AN - SCOPUS:84961216978

VL - 12

SP - 1430

EP - 1434

JO - Human Vaccines and Immunotherapeutics

JF - Human Vaccines and Immunotherapeutics

SN - 2164-5515

IS - 6

ER -